Branka Grubor‐Bauk

1.7k total citations · 1 hit paper
41 papers, 1.1k citations indexed

About

Branka Grubor‐Bauk is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Branka Grubor‐Bauk has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 20 papers in Immunology and 12 papers in Molecular Biology. Recurrent topics in Branka Grubor‐Bauk's work include Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (11 papers) and Immune Cell Function and Interaction (9 papers). Branka Grubor‐Bauk is often cited by papers focused on Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (11 papers) and Immune Cell Function and Interaction (9 papers). Branka Grubor‐Bauk collaborates with scholars based in Australia, United States and India. Branka Grubor‐Bauk's co-authors include Eric J. Gowans, Danushka K. Wijesundara, Graham Mayrhofer, Anthony Simmons, Peter Speck, Makutiro G. Masavuli, Jason Gummow, Wenbo Yu, Joseph Torresi and Zelalem A. Mekonnen and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and Scientific Reports.

In The Last Decade

Branka Grubor‐Bauk

40 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection

2022 187 citations Makutiro G. Masavuli, Zelalem A. Mekonnen et al. profile →

Peers

Branka Grubor‐Bauk

IMMUN

EPIDE

HEPAT

Gustaf Ahlén Sweden

Gennadiy Zelinskyy Germany

G. Diego Miralles United States

Ai Kawana‐Tachikawa Japan

Luke W. Meredith United Kingdom

Béatrice Jacquelin France

Kapil Bahl United States

R. Keith Reeves United States

Mattias N.E. Forsell Sweden

S. A. Stohlman United States

Gustaf Ahlén Sweden

Branka Grubor‐Bauk

280 ×0.6

IMMUN

342 ×0.9

EPIDE

248 ×0.9

237 ×0.9

332 ×1.7

HEPAT

Citations per year, relative to Branka Grubor‐Bauk Branka Grubor‐Bauk (= 1×) peers Gustaf Ahlén

Countries citing papers authored by Branka Grubor‐Bauk

Since Specialization

Citations

This map shows the geographic impact of Branka Grubor‐Bauk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Branka Grubor‐Bauk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Branka Grubor‐Bauk more than expected).

Fields of papers citing papers by Branka Grubor‐Bauk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Branka Grubor‐Bauk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Branka Grubor‐Bauk. The network helps show where Branka Grubor‐Bauk may publish in the future.

Co-authorship network of co-authors of Branka Grubor‐Bauk

This figure shows the co-authorship network connecting the top 25 collaborators of Branka Grubor‐Bauk. A scholar is included among the top collaborators of Branka Grubor‐Bauk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Branka Grubor‐Bauk. Branka Grubor‐Bauk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Dawei, Xing Wang, Letao Xu, et al.. (2025). Screening lipid nanoparticles using DNA barcoding and qPCR. Colloids and Surfaces B Biointerfaces. 251. 114598–114598. 4 indexed citations

Wignall, Anthony, Zelalem A. Mekonnen, Benjamin S.‐Y. Ung, et al.. (2025). Microfluidic Optimization of PEI-Lipid Hybrid Nanoparticles for Efficient DNA Delivery and Transgene Expression. Pharmaceutics. 17(4). 454–454.

Singer, Julian, Griffith B. Perkins, Tania Salehi, et al.. (2024). Dietary Inulin to Improve SARS-CoV-2 Vaccine Response in Kidney Transplant Recipients: The RIVASTIM-Inulin Randomised Controlled Trial. Vaccines. 12(6). 608–608. 4 indexed citations

Bremmell, Kristen E., et al.. (2024). Enhancing non-viral DNA delivery systems: Recent advances in improving efficiency and target specificity. Journal of Controlled Release. 378. 170–194. 11 indexed citations

Noll, Jacqueline E., Makutiro G. Masavuli, Branka Grubor‐Bauk, et al.. (2023). Myeloperoxidase creates a permissive microenvironmental niche for the progression of multiple myeloma. British Journal of Haematology. 203(4). 614–624. 4 indexed citations

Wijesundara, Danushka K., Arthur Eng Lip Yeow, Christopher L. D. McMillan, et al.. (2023). Superior efficacy of a skin-applied microprojection device for delivering a novel Zika DNA vaccine. Molecular Therapy — Nucleic Acids. 34. 102056–102056. 6 indexed citations

Perkins, Griffith B., Julian Singer, Tania Salehi, et al.. (2022). Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)—rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients. Trials. 23(1). 780–780. 4 indexed citations

Fenix, Kevin, Danushka K. Wijesundara, Allison J. Cowin, Branka Grubor‐Bauk, & Zlatko Kopecki. (2020). Immunological Memory in Imiquimod-Induced Murine Model of Psoriasiform Dermatitis. International Journal of Molecular Sciences. 21(19). 7228–7228. 25 indexed citations

Roy, Sreeja Biswas, Zheyi Li, Sadia Mahboob, et al.. (2019). Viral vector and route of administration determine the ILC and DC profiles responsible for downstream vaccine-specific immune outcomes. Vaccine. 37(10). 1266–1276. 18 indexed citations

10.

Grubor‐Bauk, Branka, Danushka K. Wijesundara, Makutiro G. Masavuli, et al.. (2019). NS1 DNA vaccination protects against Zika infection through T cell–mediated immunity in immunocompetent mice. Science Advances. 5(12). eaax2388–eaax2388. 61 indexed citations

11.

Mekonnen, Zelalem A., Branka Grubor‐Bauk, Makutiro G. Masavuli, et al.. (2019). Toward DNA-Based T-Cell Mediated Vaccines to Target HIV-1 and Hepatitis C Virus: Approaches to Elicit Localized Immunity for Protection. Frontiers in Cellular and Infection Microbiology. 9. 91–91. 10 indexed citations

12.

Masavuli, Makutiro G., Danushka K. Wijesundara, Alexander P. Underwood, et al.. (2019). A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice. Frontiers in Immunology. 10. 1145–1145. 30 indexed citations

13.

Christiansen, Dale, L. Earnest-Silveira, Brendon Y. Chua, et al.. (2018). Antibody Responses to a Quadrivalent Hepatitis C Viral-Like Particle Vaccine Adjuvanted with Toll-Like Receptor 2 Agonists. Viral Immunology. 31(4). 338–343. 9 indexed citations

14.

Wijesundara, Danushka K., et al.. (2017). Human Rhinovirus-A1 as an Expression Vector. Methods in molecular biology. 1581. 181–201. 1 indexed citations

15.

Wijesundara, Danushka K., Jason Gummow, Steve Wesselingh, et al.. (2016). Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses. Scientific Reports. 6(1). 36658–36658. 9 indexed citations

16.

Wijesundara, Danushka K., Jason Gummow, Tamsin Garrod, et al.. (2016). A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice. Scientific Reports. 6(1). 29131–29131. 15 indexed citations

17.

Grubor‐Bauk, Branka, Wenbo Yu, Danushka K. Wijesundara, et al.. (2015). Intradermal delivery of DNA encoding HCV NS3 and perforin elicits robust cell-mediated immunity in mice and pigs. Gene Therapy. 23(1). 26–37. 25 indexed citations

18.

Yu, Wenbo, Branka Grubor‐Bauk, Tessa Gargett, Tamsin Garrod, & Eric J. Gowans. (2014). A novel challenge model to evaluate the efficacy of hepatitis C virus vaccines in mice. Vaccine. 32(27). 3409–3416. 12 indexed citations

19.

Garrod, Tamsin, Tessa Gargett, Wenbo Yu, et al.. (2014). Loss of long term protection with the inclusion of HIV pol to a DNA vaccine encoding gag. Virus Research. 192. 25–33. 6 indexed citations

20.

Gargett, Tessa, Branka Grubor‐Bauk, Darren S. Miller, et al.. (2014). Increase in DNA vaccine efficacy by virosome delivery and co‐expression of a cytolytic protein. Clinical & Translational Immunology. 3(6). e18–e18. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact